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OBJECTIVE — We investigated the relationship between carbohydrate intake and postpran-
dial blood glucose (BG) levels to determine the most inﬂuential meal for type 2 diabetic subjects
treated with basal insulin and needing prandial insulin.
RESEARCH DESIGN AND METHODS — Three-day BG proﬁles for 37 type 2 diabetic
subjects, with A1C levels of 7.7%, treated with sulfonylurea and metformin, and well titrated on
insulinglargine,wereanalyzedusingacontinuousglucosemonitoringsystem.Foodintakefrom
680 meals was recorded and quantiﬁed during continuous glucose monitoring.
RESULTS — ThemedianBGexcursion(BG)washigheratbreakfastthanatlunchordinner
(111 [81; 160] vs. 69.5 [41.5; 106] and 82.5 mg/dl [53; 119] mg/dl, P  0.0001). There was a
weak overall correlation between BG and carbohydrate intake. Correlation improved when
mealtime was taken into account. Simple relationships were established: BG (mg/dl)  65 
carbohydrate/body weight  73 for breakfast (R
2  0.20, P  0.0001); the slope was reduced
by half at lunch and by one-third at dinner. Twelve relevant variables likely to affect BG were
integrated into a polynomial equation. This model accounted for 49% of BG variability. Two
groups of patients were identiﬁed: responders, in whom BG was well correlated with carbo-
hydrate intake (R
2  0.30, n  8), and nonresponders (R
2  0.30, n  29). Responders
exhibited a greater insulinopenic proﬁle than nonresponders.
CONCLUSIONS — The carbohydrate intake in responders clearly drives BG, whereas, in
nonresponders, other factors predominate. This sort of characterization should be used to guide
therapeutic choices toward more targeted care with improved type 2 diabetes management.
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I
n type 2 diabetes, large controlled clin-
ical trials have shown that intensive
treatment of diabetes can signiﬁcantly
decrease the development and/or pro-
gression of microvascular and macrovas-
cular complications associated with the
disease (1,2). Until recently, therapy has
mainly focused on lowering A1C levels,
with a strong emphasis on fasting plasma
glucoselevels(3).Intheeventoffailureof
oral antidiabetic treatment at a maximum
dose, the addition of a single bedtime in-
jection of a long-acting insulin analog is
recommended to reduce A1C to below
7%(3,4).However,whilecombinedbasal
insulin and oral antidiabetic drugs
(OADs) usually normalize fasting glucose
levels in the morning (5,6), A1C remains
above7%inaroundhalfofthesepatients.
Failure to optimize glycemic control is
mainly due to a persistent elevation in
postprandial blood glucose (PPBG) levels
(7). Interventional trials support the view
that controlling fasting hyperglycemia is
necessary but usually insufﬁcient for
achievingatargetA1Cof7%,thusmak-
ing control of postprandial hyperglyce-
miaessential.Moreover,PPBGexcursions
lead to oxidative stress by generating re-
active oxygen species and to inﬂamma-
tion and endothelial dysfunction (8);
indeed, all these phenomena are involved
in micro- and macrovascular diabetes
complications. These data emphasize the
need for good control of PPBG.
Guidelines have been proposed for
the management of PPBG values, but
there is currently no consensus regarding
the target value, which is a peak value of
180 (5) or 140 mg/dl 2 h after meals
(8,9). Many authors recommend a PPBG
level of 140 mg/dl 2 h after the start of a
meal,toachievenormalglucosetolerance
according to the standards of oral glucose
tolerance testing. A single injection of
prandialinsulin,inadditiontobasalinsulin
andOADtherapy,targetedatthemainmeal
(i.e., the meal with the highest PPBG
excursion), represents a stepwise approach
toward intensifying insulin therapy. How-
ever, it is not always easy to determine the
main meal of the day for any given patient,
sincethiscanvaryaccordingtocountryand
customs and is also dependent on the indi-
vidual patient’s eating habits. It is neverthe-
less vital to ascertain the patient’s main
meal, to treat the principal daily PPBG ex-
cursion effectively.
Of the factors potentially affecting
PPBGlevels,totalcarbohydrateintakehas
beenshowntobeaconsistentpredictorof
PPBGconcentrations(10),inbothsingle-
meal (11) and mixed-meal studies (10).
However, while PPBG excursion is di-
rectly linked to carbohydrate (CHO)
levelsintype1diabetes(12),therelation-
ship is more complex in type 2 diabetes,
primarily because of residual insulin se-
cretion and insulin resistance. As a result,
CHO alone is not a reliable predictor of
glycemicexcursionintype2diabeticsub-
jects (13), thus suggesting the involve-
ment of other factors.
We aimed to analyze the relationship
betweenthequantityofcarbohydratesin-
gested in a meal and subsequent PPBG
excursion in type 2 diabetic subjects pre-
senting good fasting blood glucose (FBG)
levels.Inthiscontext,continuousglucose
monitoring systems (CGMSs) allow a
more expansive view of glycemic excur-
sions at meals. We also sought to identify
factors other than CHO that potentially
affect this relationship and to study their
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nally, we attempted to create an equation
for the prediction of postprandial excur-
sion that integrates these various factors.
RESEARCH DESIGN AND
METHODS— This was a prospective
single-center observational study de-
signed to determine the relationship be-
tween postprandial excursion and CHO
intake in type 2 diabetic subjects on
OADsandinsulinglargineandpresenting
good basal glycemic control.
Study population
A total of 37 type 2 diabetic subjects were
recruited at the Diabetes Department of
the Sud-Francilien Hospital between 9
January 2007 and 24 June 2007, either
during consultation or while they at-
tendedanoutpatientclinic.Theinclusion
criteria were as follows:
● On treatment with insulin glargine in
combination with sulfonylurea and met-
forminatmaximumtolerateddosesforat
least 3 months; no patients were taking
prandial insulin, dipeptidyl peptidase 4
inhibitors, or glucagon-like peptide 1
analogs.
● Mean FBG levels (at least 10 consecu-
tive measurements before inclusion) of
120 mg/dl. For patients with FBG
120 mg/dl, the once-daily bedtime
dose of glargine insulin was titrated to
achieve a mean monthly FBG of 120
mg/dl before inclusion.
● A1C 7%.
● Stable treatment and diet over the pre-
vious 2 months.
● Written informed consent before par-
ticipating in the study.
Methods
Patients were asked to provide two series
of 3- to 5-day CGMS blood glucose (BG)
proﬁles no more than 1 month apart.
Study organization
Patients attended the outpatient clinic on
the morning of day 1. They were required
to fast before arriving.
The baseline characteristics were re-
corded on arrival and tests for A1C, BG
value,andfastinglipidswereperformedbe-
fore breakfast. Basal and glucagon-
stimulated C-peptide levels were also
measured.
CGMS
Continuous glucose readings were taken
using a Medtronic MiniMed CGMS,
which was initialized and calibrated by
means of capillary self-monitoring of BG
measurements. The CGMS sensor was in-
serted at the hospital before or just after
lunch on day 1. In their homes, patients
wererequiredtocalibratethesensorafur-
ther three times on day 1 and then four
times per day (before breakfast, lunch,
and dinner and at bedtime) until day 4 or
5. They also had to record each meal and
perform capillary glucose tests with a
blood glucose meter six times per day:
FBG when waking up in the morning just
beforebreakfastandbefore(premeal)and
2hafterthestartofeachmeal(2-hPPBG).
On day 4 or 5, patients returned to the
hospital to have the CGMS sensor re-
moved, and the results were downloaded
onto the physician’s computer. At the
same time, patient diaries for self-
monitoring of BG levels and recording
food intake were collected. A 24-h tele-
phone hotline was available for patients
during the CGMS proﬁle phase.
We obtained a second CGMS proﬁle,
under similar conditions to the ﬁrst,
within 1 month.
Dietary survey
During each CGMS proﬁle period, pa-
tientswereaskedtoeatnormally,without
taking any snacks, and were asked to ab-
stain from any physically demanding ac-
tivities. Patients were free to follow their
regular diets. They were asked to record
precisely in a diary what they ate after
each meal. Diaries with weighed food
were then analyzed by two dietitians, to
assessCHO,lipid,protein,andcaloriein-
take at each meal. In cases of discrepancy
between the two surveys, data were re-
viewed by both and a decision was taken
together. To have a broad amplitude of
CHO values and be able to accurately an-
alyze the correlation between PPBG ex-
cursion and CHO amount, patients were
asked to double the carbohydrate intake
once a day in one of the three meals
(breakfast,lunch,ordinner),basedonthe
recommendations of the dietitian (“car-
bohydrate-loaded” meals) in both CGMS
periods.
Data analysis
Descriptive analyses. Data from all
meals (n  680) were ﬁrst analyzed. For
each type of meal (breakfast, lunch, and
dinner), meal start times were superim-
posed (time 0) and mean 4-h postpran-
dial BG proﬁles were then analyzed.
Analysis of correlation
The overall correlation between post-
prandial blood glucose excursion (PBG)
and CHO intake was assessed for all pa-
tients. Four criteria were used to study
PBG:1)PPBGmax(0–4 h)–preprandialBG
(or FBG for breakfast), 2) 2-h PPBG–
preprandial BG (or FBG for breakfast), 3)
AUC(0–3 h), and 4) AUC(0–4 h). The ﬁrst
criterion exhibited the best correlation
betweenCHOandPBG;itwasthuscon-
sidered as representative of PBG and
was selected for subsequent analyses.
These analyses of correlation were re-
peated, substituting CHO intake for the
ratio of CHO content/body weight. Simi-
lar analyses were repeated, taking into ac-
countthemealtime(breakfast,lunch,and
dinner).
Modeling analysis
To ensure data reliability, only results
fromtheﬁrst3daysofeachCGMSproﬁle
were used for modeling (n  593).
Selected variables
Variables likely to affect PBG were col-
lected for each patient, i.e., 1) demo-
graphics(age,sex);2)variablesassociated
with the meal (CHO, lipid and protein
content, time of meals and type of meals
[normal or “carbohydrate-loaded”]); 3)
variables associated with metabolic con-
trol (A1C, FBG, and premeal BG values);
and 4) variables affecting insulin resis-
tance evaluation (basal and stimulated C-
peptide, waist circumference, BMI, waist-
to-hip ratio, and the coefﬁcient of insulin
sensitivity [K][ K  basal insulin dose/
0.35  weight in kilograms] [12]). In the
event of a good correlation between two
of these variables, only the most relevant
one was selected for subsequent analyses.
Whole population
The aforementioned variables were stud-
ied in a polynomial equation. The poly-
nomial equation that gave the best
prediction was assessed using a stepwise
method(withasigniﬁcancelevelforentry
value and for a stay value in the model
equal to 0.10). A mixed model analysis of
variance using an autoregressive correla-
tion structure with patients as a random
factor was also tested to take into account
thepotentialcorrelationbetweeneachpa-
tient’s measurements. The two main fac-
tors affecting PBG (CHO intake and
mealtime) were incorporated as ﬁxed fac-
tors. All of these models were compared
for their ability to predict variability in
PBG.
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The correlation between carbohydrate in-
take and PBG was also studied for each
patient,andallpatientswereclassiﬁedac-
cording to the degree of correlation be-
tween PBG and CHO intake.
Statistical analysis
Sample size. We planned to recruit 40
patients to obtain at least 30 complete
evaluable observations; this would result
inatotalof540usableprandialvalues(30
patients, two CGMS proﬁles with nine
mealsperpatientthatcouldbeanalyzed),
thus rendering 180 values for each of the
three meals available for analysis.
Data analysis
SPSS 15 for Windows was used for de-
scriptive statistical analysis, and the re-
sults were reported as mean  SD if the
data followed normal distributions; com-
parisons were thus performed using a
one-way ANOVA; otherwise, data were
presented as the median and interquartile
range (median [interquartile range]), and
comparisons were performed using a
Kruskal-Wallis one-way ANOVA. Statis-
tical signiﬁcance for two-sided tests was
set at P  0.05.
SAS9.1forWindowsXPwasusedfor
modeling analyses. All models were com-
pared using the R
2 coefﬁcients for poly-
nomial and linear equations or Akaike’s
information criteria for mixed models,
with the best prediction being considered
for the highest R
2 coefﬁcients and for the
lowest Akaike’s information criteria val-
ues, respectively.
RESULTS
Study population
The 37 type 2 diabetic subjects (25 men,
12 women) included in the study were
treated with sulfonylurea, metformin,
and glargine insulin and exhibited good
initial glycemic control. These patients
wereaged646years;theyhadaBMIof
29.3  4 kg/m
2, and the mean A1C level
at baseline was 7.7  0.8%.
The baseline C-peptide value was
2.41.1ng/mlandglarginedosewas33
units/day (20; 44).
Three- to ﬁve-day BG proﬁles of the
37 type 2 diabetic subjects were recorded
using a CGMS. Proﬁles were recorded
once (n  5) or twice (n  32). The me-
dian interval between the two series of
data was 11 days (11; 18).
Postprandial blood glucose proﬁles
Data from 680 meals were analyzed for
the whole population. Mean postprandial
BG proﬁles adjusted for the start of meals
are given in Fig. 1. The median BG excur-
sion was signiﬁcantly higher at breakfast
than at lunch and dinner (111 [81; 160]
vs. 69.5 [41.5; 106] and 82.5 [53; 119]
mg/dl, P  0.0001), for a median CHO
intakeof52[40;70],77[53;113],and72
[50;98]gatbreakfast,lunch,anddinner,
respectively. Maximum PPBG excursion
occurred around 110 min after the begin-
ning of the meal. However, the time to
peak excursion was signiﬁcantly shorter
at breakfast than at lunch or dinner (95
[75; 120] vs. 120 [80; 180] min, and 125
[95; 190] min, P  0.0001).
Relationship between postprandial BG
excursion and CHO intake. The initial
overallanalysisofthe680mealsshoweda
weak correlation between BG excursion
and CHO intake, whatever the represen-
tations of postprandial BG excursion (R
2:
0.06–0.09); however, PPBGmax(0–4 h)–
preprandial BG (or FBG for breakfast),
designed as BG, showed the best corre-
lation and was thus used for subsequent
analyses. This correlation improved
slightly after an adjustment for body
weight (data not shown).
The correlation between BG and
CHO improved when the mealtime was
taken into account, with better correla-
tion for breakfast and dinner than for
lunch. Using the regression curve equa-
tion for each meal, a simple overall rela-
tionship was established between BG
andCHOintake.Forbreakfast,BG(mg/
dl)  65  carbohydrate/body weight 
73(R
20.20,P0.0001);theslopewas
reducedbyhalfatlunch(a32,constant
b  43, R
2  0.09, P  0.0001) and by
Figure 1—The 4-h PPBG proﬁles: the start times of all meals (breakfasts, lunches, and dinners) were superimposed in the analysis (time 0). PPBG
analysis was then performed over a period of 4 h from time 0. Median BG was signiﬁcantly higher at breakfast than at lunch and dinner (111 [81;
160]vs.69.5[41.5;106]and82.5[53;119]mg/dl,P0.0001).MedianpeakBGexcursionwasreached110min(80;165)afterthestartofmeals,
but differed according to meal type (95 [75; 120] min at breakfast vs. 120 [80; 180] min at lunch and 125 [95; 190] min at dinner, P  0.0001).
Franc and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 9, SEPTEMBER 2010 1915one-third at dinner (a  53, constant b 
36, R
2  0.2, P  0.0001).
These correlation analyses indicated
that, for the same CHO content, BG was
twice as high at breakfast and two-thirds
higher at dinner than at lunch. These lin-
earapproacheswerethencompletedwith
multivariate polynomial analyses to in-
crease the predictive ability of the model.
BG modeling
The data for the ﬁrst 3 days of the BG
proﬁleswereanalyzedforBGmodeling.
Whole population: development of a
polynomial equation
Available relevant criteria likely to affect
BG excursion were listed, and 12 of them
were integrated into a polynomial equa-
tion. These variables included CHO con-
tent (g), mealtime (breakfast, lunch, or
dinner), type of meal (carbohydrate-
loaded, postcarbohydrate-loaded, or nor-
mal meals), BMI (kg/m
2), baseline
C-peptide (ng/ml), coefﬁcient of insulin
sensitivity (K), protein content (g), A1C
(%), preprandial BG (or FBG for break-
fast) value (mg/dl), age (years), waist cir-
cumference (cm), and waist-to-hip ratio.
We checked that these 12 variables were
not too highly correlated to continue the
analysis (pair-wise correlation coefﬁ-
cients always below 0.65). BG was ﬁ-
nally expressed as follows:
BG  507.6  1.0 (CHO)
 199.0 (A1C)  29.9 (BMI)
 0.44 (preprandial BG or
FBG for breakfast)
 36.5 (breakfast) or 7.8 (lunch)
 19.2 (carbohydrate-loaded meal)
 23.2 (C-peptide)  42.8 (K)
 8.6 (waist circumference)
 181.5 (waist-to-hip ratio)
 33.0 (age)  0.0023 (CHO)
2
 14.2 (A1C)
2  0.44 (BMI)
2
 2.80 (C-peptide)
2  9.44 (K)
2
 0.039 (waist circumference)
2
 0.01 (protein)
2  0.24 (age)
2
with R
2  49%; this suggested that 49%
of BG variability could be accounted for
using this model. The variables with the
greatest bearing on BG excursion were
CHO intake and mealtime, with respec-
tive contributions of 15 and 9% to BG
variability. Analysis of the other three cri-
teria for PPBG excursion [PPBG2h–
preprandial BG (or FBG for breakfast),
AUC(0–3 h), and AUC(0–4h)] showed sim-
ilar results, with R
2 coefﬁcients of around
0.50(0.49–0.52).Thus,halfofBGvari-
ability can be accounted for using the se-
lected variables.
Restricting BG modeling to a simple
ﬁrst-degree equation using the six main
variablesresultedinsimpliﬁedexpression
of BG: BG  46  0.6 (CHO)  [46
(breakfast) or 12 (lunch)]  2 (BMI) 
3.6 (C-peptide)  12 (A1C)  0.34 (pre-
prandial BG or FBG for breakfast). This
model accounted for 38% of BG
variability.
A mixed-effect model was suggested
to take into account the probable correla-
tion between repeated measures in the
same patient. Analysis was conducted on
CHO intake and mealtime, both of which
were independent factors (P  0.0001),
but use of this linear model did not im-
prove the predictive value.
Individual data
A regression curve between CHO intake
and BG was traced for each patient, and
the R
2 coefﬁcient of determination was
considered. Individual data analysis re-
vealed high inter-individual variability,
with certain patients, labeled “respond-
ers,” showing good correlation between
BGandcarbohydrateintake(R
20.30,
n  8) and others, termed “nonre-
sponders,” exhibiting poor correlation
(R
2  0.30, n  29) (Fig. 2).
Therewasnodifferenceregardingthe
duration of the disease between re-
sponder and nonresponder patients. Re-
sponderswereleanerthannonresponders
(BMI 26.5  3.1 vs. 30.1  3.9 kg/m
2,
P  0.019); they had higher median
PPBG excursions (BG, 103 [62; 151] vs.
85 [53; 124] mg/dl, P  0.001) and had a
lowermedianCHOintake(60[43;91]vs.
67 [48; 96] g, P  0.027). Their median
lipid intake was also higher (26 [16; 40]
vs. 22 [12; 32] g, P  0.001). There was
no difference in the median calorie con-
tent per meal (635 [425; 892] vs. 614
[396;838]kcal/meal,P0.247),butthe
median calorie content per meal and per
kilosigniﬁcantlydifferedbetweenthetwo
populations (7.92 [5.34; 11.52] vs. 7.25
[4.61; 9.82] kcal/meal/kg, P  0.03).
Among responders, there was a trend to-
wardalowerbasalC-peptidevalue(1.8
0.7 vs. 2.4  1.3 ng/ml, P  0.11) and a
lower glargine dose (20 [18; 42] vs. 35
[24; 44] units, P  0.245).
CONCLUSIONS — There is increas-
ing evidence that PPBG excursion has a
harmful effect on arterial wall (8) and is
involved in both the microvascular (14)
and macrovascular complications of dia-
betes (15). Strategies to minimize PPBG
concentrations are thus essential to re-
Figure 2—Linear relationship between CHO intake based on weight and BG for a responder (A) (good correlation between CHO intake/weight
and BG) and for a nonresponder (B) (no correlation between CHO intake/weight and BG).
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subjects. Our study was conducted in a
population of type 2 diabetic subjects
with good baseline fasting BG levels and
took into account only those factors af-
fectingPPBGexcursions.Manyfactorsin-
ﬂuence PPBG excursion, with CHO
intake playing a key role. It is now ac-
cepted that the actual CHO content of
meals is more important than the source
or type of CHO (16). In addition to the
CHO intake level, the time of the meal
also contributes considerably to BG ex-
cursion.Pearceetal.(13)haveshownthat
type 2 diabetic subjects on randomized
dietary therapy, who even consume CHO
throughout the day (70 g CHO per meal),
displayedahigherBGexcursionatbreak-
fast than at lunch or dinner. Similarly, in
our study, the highest median BG excur-
sion was observed for breakfast. How-
ever,oneofourmainﬁndingswasthatfor
the same CHO intake the peak BG excur-
sion was two times greater at breakfast
and was two-thirds greater at dinner than
at lunch. The higher BG excursion after
breakfast may be due to the “dawn phe-
nomenon,” a dysregulation of the normal
circadian hormonal patterns resulting in
increased hepatic glucose output and de-
creased glucose utilization.
The weak correlation between glyce-
micexcursionandCHOintakeatindivid-
ual meals suggests that factors other than
CHO and mealtime are involved in PPBG
excursion. Variables likely to affect PPBG
levelswereselectedtomodelPPBGexcur-
sion. A 12-variable polynomial equation
was derived, allowing a prediction of up
to 50% of BG variability. Some of the
selected variables have already been
shown to be involved in PPBG excursion.
Protein (10) and lipid consumption (17),
preprandial glucose level (18), and sec-
ond meal effects (19) can also modify the
effects of CHO on PPBG concentrations
(13). The degree of insulin resistance also
affects PPBG excursion considerably. In
type2diabeticsubjects,insulinresistance
is mostly due to an absence of glucagon
prandialsecretionsuppression(20),lead-
ing to an increase in hepatic glucose pro-
duction (21). Several variables used to
assess insulin resistance were included in
our models: waist circumference, waist-
to-hipratio,BMI,weight,insulinsensitiv-
ity coefﬁcient (K), and C-peptide. Insulin
resistance, which differed widely from
onepatienttoanother,alsocontributedto
BG variability.
The remaining 50% of BG variabil-
ity may be due to parameters not assessed
in our study. The glycemic index of food
and the dietary glycemic load may also be
involved; these factors would allow the
prediction of the relative ranking of PPBG
and insulin responses to mixed meals
(22). However, in a meta-analysis of ran-
domized controlled trials, diets with a
lower glycemic index were associated
with only a modest improvement in A1C
(0.43%) (23). Cooking methods, pro-
cessing methods, and the form of foods
also inﬂuence PPBG excursion to a lesser
extent. As well as meal composition, gas-
tric emptying contributes to PPBG values
(21), possibly via incretin factors. The
gastric emptying rate, which has been
shown to be inﬂuenced by diabetes (24),
can induce some variation in peak BG
levels and the time at which peak BG
levelsoccur.Inourstudy,peakBGexcur-
sion occurred around 110 min after the
start of meals versus 45 min in healthy
volunteers (25), and we observed a di-
verse range of values. Pearce et al. (13)
reported similar variation in maximum
glucose response times to a CHO load,
with differences in the observed lag time
of up to 105 min.
One of the main hurdles to a more
accuratepredictionofBGexcursionisthe
wide variation in inter-individual data.
Based on individual data, two groups of
patients were identiﬁed: responders to
CHO intake, in whom BG correlated
closely with CHO intake, and nonre-
sponders, who showed a lower correla-
tion. Responders were leaner than
nonresponders and tended to have lower
BMI or waist-to-hip ratios and lower C-
peptide values. Responders had signiﬁ-
cantly higher PPBG excursions than
nonresponders, whereas their CHO in-
take was signiﬁcantly lower. One cannot
rule out the possibility that responders
might have reduced CHO intake to limit
BG excursions. Responders tended to
consume more lipids per meal, but the
calorie intake did not differ signiﬁcantly
from that of nonresponders. While the
low number of responders underscores
the need for caution, these subjects had a
more insulinopenic proﬁle than nonre-
sponders, who exhibited higher insulin
resistance.
The strength of this study is based on
the use of a CGMS, which allows detec-
tionofdynamicchangesinBGconcentra-
tions unidentiﬁable using intermittent
self-monitoring of blood glucose. This
study was conducted in “typical” type 2
diabeticoutpatientseatingasnormal,and
we took care to limit sources of variability
during the CGMS proﬁle phase (no
snacksandnoabnormalphysicalexertion
during this phase).
Theaimofthisstudywastoassessthe
relationship between BG excursion and
CHO intake in ambulatory subjects with
type 2 diabetes. Several conclusions can
be drawn from our study: 1) breakfast
seems to be the principal meal in France,
i.e., the meal incurring the highest BG ex-
cursion. For the same CHO intake, com-
pared with lunchtime, BG excursion was
twice as high at breakfast and two-thirds
higher at dinner. 2) BG excursion can be
predictedfairlywellusinganequationin-
corporating CHO, lipid, and protein in-
take and mealtimes; preprandial BG
values (or FBG for breakfast); A1C; basal
C-peptide; BMI; waist-to-hip ratio; and
age. 3) Two categories of patients were
indentiﬁed according to degree of corre-
lation between BG values and CHO in-
take. In insulinopenic patients, CHO
intake clearly causes an increase in PPBG,
whereas, in insulin-resistant patients,
factors other than the CHO load predom-
inate. This type of patient proﬁle charac-
terization should be used to guide
therapeutic choices, favoring more tar-
geted care and improved type 2 diabetes
management.
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